1. Home
  2. SBET vs ODTX Comparison

SBET vs ODTX Comparison

Compare SBET & ODTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SharpLink Gaming Ltd.

SBET

SharpLink Gaming Ltd.

BUY

Current Price

$7.47

Market Cap

1.4B

Sector

Technology

ML Signal

BUY

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

HOLD

Current Price

$18.37

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBET
ODTX
Founded
1995
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2025
2025

Fundamental Metrics

Financial Performance
Metric
SBET
ODTX
Price
$7.47
$18.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
8
Target Price
$16.63
★ $35.33
AVG Volume (30 Days)
★ 6.6M
246.3K
Earning Date
11-11-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $28,055,000.00
N/A
Revenue This Year
$67.70
N/A
Revenue Next Year
$57.94
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 666.04
N/A
52 Week Low
$4.46
$15.10
52 Week High
$14.85
$29.05

Technical Indicators

Market Signals
Indicator
SBET
ODTX
Relative Strength Index (RSI) 35.31 41.44
Support Level $6.05 $15.10
Resistance Level $8.20 $19.60
Average True Range (ATR) 0.43 1.35
MACD -0.26 -0.16
Stochastic Oscillator 1.86 23.11

Price Performance

Historical Comparison
SBET
ODTX

About SBET SharpLink Gaming Ltd.

Sharplink Inc is one of those publicly traded companies to adopt ETH as its primary treasury reserve asset. This move reflects the Company's commitment to align corporate treasury with the future of programmable finance, digital capital markets, and decentralized infrastructure. The Company also operates an online affiliate marketing company that delivers different fan activation solutions to its sportsbook and online casino gaming partners. The company operates in two reportable segments: ETH Treasury Management and Affiliate Marketing. The majority of its revenue is generated from the ETH Treasury Management. Geographically, the company operates in the United States and the rest of the world.

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Share on Social Networks: